NCT05653310
Tradipitant for Functional Dyspepsia
Enrolling by Invitation
PHASE2Ages 18–70InterventionalBasic scienceXiao Jing (Iris) WangInvestigator-initiated
~60 participants
Updated 2026-07-16 on ClinicalTrials.gov
What's tested:TradipitantPlacebo
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Accommodation gastric volumes measured by single photon emission computed tomography (SPECT)
Measured over 4 Weeks
Conditions
Where it's being run
1 sites across 1 statesMinnesota1
Study leadership
- Xiao Jing (Iris) Wang, MD · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Able to provide written consent
Body Mass Index (BMI) of 18-35 kg/m2
Absence of other diseases which could interfere with interpretation of study results
Exclusion
Current H. pylori infection
Pregnancy or nursing
Recent history of Alcohol Use Disorder or Substance Use Disorder
What this trial measures
- Accommodation gastric volumes measured by single photon emission computed tomography (SPECT)4 Weeks